Harbour Investments’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 4666
2025
Q4
$2 Hold
1
﹤0.01% 3855
2025
Q3
$3 Hold
1
﹤0.01% 3737
2025
Q2
$4 Hold
1
﹤0.01% 3597
2025
Q1
$3 Hold
1
﹤0.01% 3545
2024
Q4
$6 Hold
1
﹤0.01% 3476
2024
Q3
$3 Hold
1
﹤0.01% 3386
2024
Q2
$3 Hold
1
﹤0.01% 3281
2024
Q1
$2 Hold
1
﹤0.01% 3210
2023
Q4
$3 Hold
1
﹤0.01% 3123
2023
Q3
$3 Hold
1
﹤0.01% 2988
2023
Q2
$4 Hold
1
﹤0.01% 3019
2023
Q1
$7 Hold
1
﹤0.01% 2988
2022
Q4
$6 Hold
1
﹤0.01% 2986
2022
Q3
$0 Hold
1
﹤0.01% 2810
2022
Q2
$0 Buy
+1
New +$46 ﹤0.01% 2810
2021
Q4
$0 Hold
1
﹤0.01% 3475
2021
Q3
$0 Hold
1
﹤0.01% 3934
2021
Q2
$0 Hold
1
﹤0.01% 3929
2021
Q1
$0 Buy
+1
New +$123 ﹤0.01% 3700

Other funds holding RKDA

Harbour Investments's RKDA Position: Q1 2026 in Review

Harbour Investments held its Arcadia Biosciences (RKDA) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4666.

Harbour Investments first reported a position in RKDA in Q1 2021 and has held it in 20 quarters since. The position peaked at $7 in Q1 2023. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Harbour Investments held 1 share of Arcadia Biosciences worth $1 as of Q1 2026.
  • Harbour Investments left its Arcadia Biosciences share count unchanged in Q1 2026.
  • Arcadia Biosciences made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4666 holding.
  • Harbour Investments first reported a position in Arcadia Biosciences in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Arcadia Biosciences position peaked at $7 in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.